Liver Diseases  >>  elbasvir (MK-8742)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
elbasvir (MK-8742) / Merck (MSD)
NCT01532973: Safety, Pharmacokinetics and Pharmacodynamics of Elbasvir (MK-8742) in Hepatitis C Infected Males (MK-8742-002)

Completed
1
48
NA
Elbasvir, Placebo
Merck Sharp & Dohme LLC
Hepatitis, Viral, Human
05/13
05/13
NCT01797536: The Influence of Hepatic Insufficiency on the Pharmacokinetics of Elbasvir (MK-8742) (MK-8742-009)

Completed
1
31
US
Elbasvir
Merck Sharp & Dohme LLC, Celerion
Hepatic Insufficiency
08/14
08/14

Download Options